Biomarkers in Heart Failure with Preserved Ejection Fraction: Problems and Opportunities

Publisher： Karger

E-ISSN： 1421-9751|136|4|228-229

ISSN： 0008-6312

Source： Cardiology, Vol.136, Iss.4, 2016-11, pp. : 228-229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical Application of Biomarkers in Heart Failure with a Preserved Ejection Fraction: A Review

By  

Cardiology, Vol. 136, Iss. 3, 2016-10 ,pp. : 192-203

Karger

Access to resources Recommend Favorite

Biomarkers and prognostication in heart failure with reduced and preserved ejection fraction: similar but different?

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 19, Iss. 12, 2017-12 ,pp. : 1648-1650

John Wiley & Sons Inc

Access to resources Recommend Favorite

Diagnosing heart failure with preserved ejection fraction

By Becher Peter Moritz   Lindner Diana   Fluschnik Nina   Blankenberg Stefan   Westermann Dirk  

Expert Opinion on Medical Diagnostics, Vol. 7, Iss. 5, 2013-09 ,pp. : 463-474

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy of Heart Failure with Preserved Ejection Fraction

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 4, 2015-04 ,pp. : 351-360

John Wiley & Sons Inc

Access to resources Recommend Favorite

Heart failure with preserved ejection fraction: uncertainties and dilemmas

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 7, 2015-07 ,pp. : 665-671

John Wiley & Sons Inc

Access to resources Recommend Favorite